mRNA |
Talazoparib |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0006 |
mRNA |
SGC0946 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
A-770041 |
GDSC1000 |
pan-cancer |
AAC |
-0.16 |
0.002 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
cimetidine |
CTRPv2 |
pan-cancer |
AAC |
-0.22 |
0.002 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.003 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.003 |
mRNA |
ouabain |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
0.004 |